James L. Cave - 04 May 2024 Form 3 Insider Report for Teladoc Health, Inc. (TDOC)

Role
INTERIM CAO
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
04 May 2024
Net transactions value
$0
Form type
3
Filing time
06 May 2024, 16:05:21 UTC
Next filing
04 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TDOC Common Stock 10,448 04 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TDOC Employee Stock Option (right to buy) 04 May 2024 Common Stock 1,493 $151.53 Direct F1
holding TDOC Restricted Stock Units 04 May 2024 Common Stock 220 Direct F2, F3
holding TDOC Restricted Stock Units 04 May 2024 Common Stock 1,356 Direct F3, F4
holding TDOC Restricted Stock Units 04 May 2024 Common Stock 1,917 Direct F3, F5
holding TDOC Restricted Stock Units 04 May 2024 Common Stock 1,001 Direct F3, F6
holding TDOC Restricted Stock Units 04 May 2024 Common Stock 9,301 Direct F3, F7
holding TDOC Restricted Stock Units 04 May 2024 Common Stock 15,000 Direct F3, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested as to 25% of the shares on November 1, 2022. The remainder of the shares vest in 36 substantially equal monthly installments thereafter.
F2 On November 1, 2021, the reporting person was granted 660 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
F3 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F4 On April 1, 2022, the reporting person was granted 4,067 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On June 1, 2022, the reporting person was granted 4,598 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On June 1, 2022, the reporting person was granted 4,002 restricted stock units, vesting in four substantially equal semiannual installments beginning on the six-month anniversary of the grant date.
F7 On March 3, 2023, the reporting person was granted 13,951 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F8 On March 1, 2024, the reporting person was granted 15,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Remarks:

Exhibit 24 -- Power of Attorney